Maximizing donors with viral hepatitis in the current era

Authors

Kimberly A. Brown, Henry Ford HealthFollow

Recommended Citation

Liver Transpl 2017; 23(S1):S44-s49.

Document Type

Article

Publication Date

10-1-2017

Publication Title

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Keywords

Allografts, Antibiotic Prophylaxis, Antiviral Agents, Donor Selection, End Stage Liver Disease, Graft Survival, Healthcare Disparities, Hepatitis B, Hepatitis C, Humans, Liver, Liver Transplantation, Practice Guidelines as Topic, Tissue Donors, Transplant Recipients, Treatment Outcome, Vaccination, Waiting Lists

Medical Subject Headings

Allografts; Antibiotic Prophylaxis; Antiviral Agents; Donor Selection; End Stage Liver Disease; Graft Survival; Healthcare Disparities; Hepatitis B; Hepatitis C; Humans; Liver; Liver Transplantation; Practice Guidelines as Topic; Tissue Donors; Transplant Recipients; Treatment Outcome; Vaccination; Waiting Lists

PubMed ID

28846183

Volume

23

Issue

S1

First Page

44